Cargando…
Protocol for a double blind, randomised placebo-controlled trial using ondansetron to reduce vomiting in children receiving intranasal fentanyl and inhaled nitrous oxide for procedural sedation in the emergency department (the FON trial)
INTRODUCTION: Intranasal fentanyl and nitrous oxide (N(2)O) can be combined to create a non-parenteral procedural sedation regimen for children in the paediatric emergency department. This combination of intranasal fentanyl and N(2)O provides effective pain relief for more painful procedures, but is...
Autores principales: | Fauteux-Lamarre, Emmanuelle, Babl, Franz E, Davidson, Andrew J, Legge, Donna, Lee, Katherine J, Palmer, Greta M, Hopper, Sandy M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5843010/ https://www.ncbi.nlm.nih.gov/pubmed/29637190 http://dx.doi.org/10.1136/bmjpo-2017-000218 |
Ejemplares similares
-
Comparison of the Sedative Effect of Inhaled Nitrous Oxide and Intranasal Midazolam in Behavior Management and Pain Perception of Pediatric Patients: A Split-mouth Randomized Controlled Clinical Trial
por: Srinivasan, Navaneetha Krishnan, et al.
Publicado: (2021) -
Safety and physiologic effects of intranasal midazolam and nitrous oxide inhalation based sedation in children visiting Saveetha Dental College and Hospitals, India
por: Ann Preethy, Neethu, et al.
Publicado: (2022) -
Ondansetron-droperidol combination vs. ondansetron or droperidol monotherapy in the prevention of postoperative nausea and vomiting
por: Matsota, Paraskevi, et al.
Publicado: (2015) -
Intranasal Midazolam Premedication for Anxiolysis in Children Reluctant to Receive Nitrous Oxide Sedation via Nasal Hood: An In Vivo Randomized Control Trial
por: Musani, Iqbal, et al.
Publicado: (2021) -
Comparative Study of the Effect of Oral Chloral Hydrate and Intranasal Fentanyl on Sedation in Children for Electroencephalography
por: SHAF, Amir, et al.
Publicado: (2023)